Customized Treatment Plan: Based on your needs, we develop a personalized program that includes GLP-1 medications, nutritional guidance, and lifestyle coaching
In the meantime, clarity is the main objective for prescription drug packaging, according to DiVaccaro
Muscle mass preservation is an important consideration given the risk of sarcopenic obesity: weight loss with GLP-1 RAs includes a lean mass component (approximately 25%-40% of total weight loss), though the clinical significance in MASLD patients without sarcopenia is uncertain
The World Health Organization's When structured behavioral support addresses diet, exercise, sleep and emotional stressors that can drive abnormal weight gain, it amplifies medication efficacy, improves adherence and enhances weight loss
Most patients rest, read, or continue working during treatment